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A B S T R A C T
A series of 14 cationic derivatives of poly(aspartic acid) i.e. cationic polyaspartamides with different
(dialkylamino)alkyl and alkyl or hydroxyalkyl side groups was synthesized by nucleophilic addition on
polysuccinimide. The resulting polyaspartamides have moderate amphiphilic properties. Relationships
between the structure and ratio of side groups and in vitro properties of polyaspartamides, including their
cytotoxic and membrane-damaging activity towards human cell lines, primary skin ﬁbroblasts and
erythrocytes, were established and discussed. Cationic polyaspartamides vary in their DNA-binding,
condensing and nuclease-protecting characteristics depending on the concentration ratio of
(dialkylamino)alkyl and alkyl or hydroxyalkyl side groups. Effective cell transfection was achieved
upon polyaspartamide-mediated plasmid DNA delivery in serum-free medium in the presence of
chloroquine. Effect of serum proteins adsorption onto polyaspartamide based polyplexes, and the role of
concentration of polyplexes in culture medium in their colloidal stability and transfection process were
demonstrated. Synthesized polyaspartamides are biocompatible and long-acting gene carriers, which are
applied to cells after dilution and without washing, thus providing transfection level comparable to that
of commercial transfection reagent.
© 2016 Elsevier B.V. All rights reserved.
1. Introduction
Synthetic polymers are an important tool in pharmaceutical
engineering aimed at drug formulations with improved stability,
availability and activity (Gaspar and Duncan, 2009). A range of
different non-ionic and charged polymeric systems of synthetic or
semisynthetic origin has been introduced to industrial and
biomedical applications owing to their preferable physicochemical
properties and compliance to reproducible production compared
with natural polymers (Finch, 1983).
Polyacrylates are among the most pharmaceutically signiﬁcant
water soluble polymers synthesized by the radical polymerization
Abbreviations: a-MEM, minimum essential medium Eagle – alpha modiﬁcation; B, n-butylamine; BSA, bovine serum albumin; CMC, critical micelle concentration; CPTA,
3-(carboxypropyl)trimethyl-ammonium chloride; DEAEMA, (diethylamino)ethyl methacrylate; DEE, 2-(diethylamino)ethylamine; DEP, 3-(diethylamino)-1-propylamine;
DLS, dynamic light scattering; DMEM, Dulbecco’s modiﬁed Eagle’s medium; DME, 2-(dimethylamino)ethylamine; DMF, dimethylformamide; DMP, 3-(dimethylamino)-1-
propylamine; DMSO, dimethyl sulfoxide; DNA, deoxyribonucleic acid; DNase I, deoxyribonuclease I; EDA, N-hydroxyethyl-ethylene diamine; EDTA, ethylenediaminete-
traacetic acid; EGFP, enhanced green ﬂuorescent protein; EtOAc, ethyl acetate; FBS, fetal bovine serum; FITC, ﬂuorescein isothiocyanate; FTIR, fourier transform infrared
spectroscopy; GPC, gel permeation chromatography; H, n-hexylamine; HD, hydrodynamic diameter; HEK-293, human embryonic kidney cell line; HLB, hydrophilic-
lipophillic balance; HPLC, high performance liquid chromatography; HSF, human skin ﬁbroblasts; HY, 6-amino-1-hexanole; HYD, hydrazine monohydrate; IC50, half-maximal
inhibitory concentrations; mRNA, messenger RNA; MTT, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide); MW, average molecular weight; NMR, nuclear
magnetic resonance; N/P ratio, molar ratio of amino groups in polycation to phosphate groups of pDNA; P, propylamine; P[Asp(DET)], poly(aspartic acid) grafted with
diethylenetriamine; P[Glu(DET)], poly(glutamic acid) grafted with diethylenetriamine; PASP, poly(aspartic acid); PBLA, poly(b-benzyl-L-aspartate); PBS, phosphate buffered
saline; PC-3, human adenocarcinoma cell line; PDI, polydispersity index; PEGMA, PEG-methacrylate; pDNA, plasmid deoxyribonucleic acid; PEG, polyethylene glycol; pEGFP-
N2, plasmid vector encoding enhanced green ﬂuorescent protein; PSI, polysuccinimide; siRNA, short interference ribonucleic acid; z, zeta potential.
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